Laboratory Corporation of America Holdings logo

Laboratory Corporation of America Holdings Investor Relations Material

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. The company offers a range of tests in its human diagnostic division, which is operated under the name of LabCorp. The Division provides testing and analytical services to the clients in health care industry, pharmaceutical companies, manufacturers, academic institutions and government agencies. Its offerings include anatomic pathology services, such as fine needle aspiration cytology (FNAC), cancer genetics/genomics, oncology focused protein marker testing, genetic counseling, and targeted genomic medicine; clinical chemistry test such as quantitative immunoassays and traditional immunoassays for the detection of infectious diseases; molecular diagnostics; microbiology - includes products for culture identification and antimicrobial sensitivity determination for transplant recipients and suspected infectious disease patients. In addition, the announced plans to acquire Knight Diagnostic Laboratories from New Jersey based Knight Human Capital Management. Laboratory Corporation of America Holdingsin is based in Burlington, North Carolina

Upcoming events for

Q4 20222023-02-10

Latest company events

Ticker symbol

LH

Country

United States of America

About the company

https://www.labcorp.com

Investor Relations Page

https://ir.labcorp.com

Dig deeper into the Laboratory Corporation of America Holdings fundamentals on Quartr.

  • Conference calls from all over the world
  • Search for anything across all transcripts
  • Consensus estimates
  • Comprehensive financial data
  • Read the transcripts or scroll the deck
  • Slide decks and earnings reports
App store link
Android play link
Quartr app screenshot